Last reviewed · How we verify
NCT03634943: ENPIC
Evaluation of Nutritional Practices in the Critical Care
trial testing Patients with Nutritional Support in Nutritional Support in 642 participants. Completed in 22 March 2022.
15 September 2018
Quick facts
| Lead sponsor | Hospital Universitari de Bellvitge |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 642 |
| Start date | 23 April 2018 |
| Primary completion | 15 September 2018 |
| Estimated completion | 22 March 2022 |
| Sites | 43 locations across Spain |
Drugs / interventions tested
- Patients with Nutritional Support
Conditions studied
- Nutritional Support — all drugs for Nutritional Support →
- Intensive Care Unit — all drugs for Intensive Care Unit →
- Critical Illness — all drugs for Critical Illness →
Sponsor
Hospital Universitari de Bellvitge
Who can join
18 and older, any sex, with Nutritional Support or Intensive Care Unit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The adequacy of the artificial Nutritional Support (NS) in the critical care patient has implications in morbidity and prognosis. Clinical practice guidelines (CPG) are an important tool for healthcare professionals in their daily practice and a method of consultation for the correct treatment of patients. Also, the evidence remains low and there are important controversies regarding the NS in the critical care patient. Hypothesis: The NS generates great controversy in the professionals involved in the care of critical care patients due to the contradictory results in literature. Despite this, the CPG should serve to standardize the treatment of patients and provide a better adherence to current knowledge in this setting. The importance of NS is underestimated and there is a need to perform proper evaluation of the impact of nutrition. Objectives: To evaluate and analyze NS practices in critically ill patients in different ICUs and assess the adherence to CPGs. To evaluate the relationship of nutrition and outcomes in the ICU. Methodology: Prospective multicenter observational study. Collection of variables from different participating ICUs and the characteristics of the NS of the different admitted patients. Monitoring of nutritional practices and complications. Evaluation of outcomes (e.g. mortality, ICU complications, etc.) with NS. Expected results: Better understanding of the NS and its impact on morbidity and mortality; development of strategies to reduce low adherence to CPGs, improving the quality of care associated with this field in critical care patients; obtain clinical information that will serve as a basis for conducting intervention studies.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
The Effect of Enteral Immunonutrition in the Intensive Care Unit: Does It Impact on Outcomes?
Lopez-Delgado JC, Grau-Carmona T, Trujillano-Cabello J, García-Fuentes C, et al · · 2022 · cited 8× · PMID 35565870 · DOI 10.3390/nu14091904 -
Factors associated with the need of parenteral nutrition in critically ill patients after the initiation of enteral nutrition therapy.
Lopez-Delgado JC, Servia-Goixart L, Grau-Carmona T, Bordeje-Laguna L, et al · · 2023 · cited 5× · PMID 37693244 · DOI 10.3389/fnut.2023.1250305 -
Factors associated with the need of Parenteral Nutrition in Critically Ill patients with Enteral Nutrition Therapy
Lopez-Delgado JC, Grau-Carmona T, Bordeje-Laguna ML, Portugal-Rodriguez E, et al · · 2022 · DOI 10.21203/rs.3.rs-1979076/v1
Verify or expand the search:
- PubMed search for NCT03634943
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospital Universitari de Bellvitge trials
Trials by the same sponsor.
- NCT07522931 — Morphometric Study of the Female Pelvic and Lower Abdominal Retroperitoneum in Cadavers · recruiting
- NCT07155590 — Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia · active not recruiting
- NCT06653192 — EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial) · NA · recruiting
- NCT07178483 — Evaluation of Physical Capacity and Energy Requirements in Patients With Hypoxemic Acute Respiratory Failure · active not recruiting
- NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03634943 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitari de Bellvitge
- Last refreshed: 23 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03634943.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing